Abstract

BackgroundSubclinical thyroid dysfunction whose typical patterns include subclinical hypothyroidism and subclinical hyperthyroidism, has been indicated to be associated with an increased risk of heart failure (HF). However, the relationship between subclinical thyroid dysfunction and the clinical outcomes of HF patients is uncertain. This meta-analysis was conducted to assess the association between subclinical thyroid dysfunction and the clinical outcomes of HF patients.MethodsPubmed, Embase, Web of Science and Cochrane Central Register of Clinical Trials were searched for eligible studies published up to August 1, 2018 which reported the association between subclinical thyroid dysfunction and the clinical outcomes of HF patients. The pooled hazard ratio (HR) with the corresponding 95% confidence interval (CI) was used to assess the association.ResultsFourteen studies met the eligibility criteria and a total of 21,221 patients with heart failure were included in the meta-analysis. Compared with HF patients with euthyroidism, the pooled HR of subclinical hypothyroidism for all-cause mortality was 1.45 (95% CI 1.26–1.67) in a randomized effects model with mild heterogeneity (I2 = 40.1, P = 0.073). The pooled HR of subclinical hypothyroidism for cardiac death and/or hospitalization was 1.33 (1.17–1.50) in a randomized effects model with moderate heterogeneity (I2 = 69.4, P < 0.001). Subclinical hyperthyroid can increase the risk of all-cause mortality without heterogeneity (HR 1.31, 95% CI 1.10–1.55, I2 = 25.5%, P = 0.225) but have no influence on the risk of cardiac death and/or hospitalization (HR 1.03, 95% CI 0.87–1.23, I2 = 0.0%, P = 0.958). These significant adverse associations were also retained in subgroup analysis. Sensitivity analysis demonstrated the stability of the results of our meta-analysis.ConclusionsBoth subclinical hypothyroidism and subclinical hyperthyroidism are associated with adverse prognosis in patients with HF. Subclinical thyroid dysfunction may be a useful and promising predictor for the long-term prognosis in HF patients.

Highlights

  • Subclinical thyroid dysfunction whose typical patterns include subclinical hypothyroidism and subclinical hyperthyroidism, has been indicated to be associated with an increased risk of heart failure (HF)

  • It has been acknowledged that both subclinical hypothyroidism and subclinical hyperthyroidism can be a cause of HF and the American College of Cardiology/American Heart Association guidelines for the diagnosis and management of heart failure on adults recommend measurement of thyroid function [14]

  • Quality assessment was performed according to the following criteria: 1) methods of outcome adjudication and ascertainment accounted for confounders and completeness of follow-up ascertainment; 2) study populations considered a convenience or a population-based sample; 3) appropriate inclusion and exclusion criteria; 4) thyroid function measured more than once; 5) methods of outcome adjudication categorized as use of formal adjudication procedures and adjudication without knowledge of thyroid status; 6) adjustments made for age, sex, New York Heart Association (NYHA)

Read more

Summary

Introduction

Subclinical thyroid dysfunction whose typical patterns include subclinical hypothyroidism and subclinical hyperthyroidism, has been indicated to be associated with an increased risk of heart failure (HF). It has been acknowledged that both subclinical hypothyroidism and subclinical hyperthyroidism can be a cause of HF and the American College of Cardiology/American Heart Association guidelines for the diagnosis and management of heart failure on adults recommend measurement of thyroid function [14]. Though subclinical hypothyroidism and subclinical hyperthyroidism are associated with an increased risk of HF, the relationship between them and the clinical outcomes of HF patients is uncertain. Some studies described an increased risk of all-cause mortality or hospitalization for HF patients with subclinical hypothyroidism or subclinical hyperthyroidism but others did not. Considering the small number of HF patients with subclinical hypothyroidism or subclinical hyperthyroidism in most studies, the results may lack statistical power

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call